Polydex Pharmaceuticals Ltd (OTCMKTS:POLXF)’s stock price passed below its 200-day moving average during trading on Thursday . The stock has a 200-day moving average of $0.92 and traded as low as $0.91. Polydex Pharmaceuticals shares last traded at $0.91, with a volume of 800 shares.
The company has a market cap of $3.12 million, a price-to-earnings ratio of 30.35 and a beta of 0.57. The business’s fifty day moving average price is $0.88 and its 200 day moving average price is $0.92. The company has a debt-to-equity ratio of 0.03, a current ratio of 3.78 and a quick ratio of 2.39.
Polydex Pharmaceuticals Company Profile (OTCMKTS:POLXF)
Polydex Pharmaceuticals Limited, through its subsidiaries, manufactures bulk pharmaceutical intermediates for the veterinary pharmaceutical industry worldwide. It also develops, manufactures, and markets biotechnology-based products for the human pharmaceutical market. The company primarily offers dextran and derivative products, including Iron Dextran, a derivative of dextran that is injected into pigs at birth as a treatment for anemia; and dextran sulphate, a specialty chemical derivative of dextran used in biotechnology applications and the pharmaceutical industry.
Featured Article: Price to Earnings Ratio (PE) Basics
Receive News & Ratings for Polydex Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Polydex Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.